OrthoPediatrics Corp. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| OrthoPediatrics Corp. | KIDS - NASDAQ |
$12.00-$14.00 | $13.00 | $18.00 | 4 million | 10/12/2017 |
| Piper Jaffray, Stifel | ||||||
Co-Manager(s): William Blair, BTIG | ||||||
| Health Care | ||||||
Filing(s): Filed 2016-06-16 Updated Prospectus 2017-08-10 Terms Added 2017-10-02 | ||||||
OrthoPediatrics Corp. Quote & Chart - Click for current quote - KIDS
IPO Boutique aggregates information on public companies and private companies, such as "KIDS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About OrthoPediatrics Corp. (adapted from OrthoPediatrics Corp. prospectus):
They are the only medical device company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market in order to improve the lives of children with orthopedic conditions.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are the only medical device company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market in order to improve the lives of children with orthopedic conditions.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "KIDS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.